Duloxetine
Product Images NDC 50436-0387

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50436-0387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 01)

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 02)

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 03)

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 04)

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 05)

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 06)

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 07)

FDA Label Image

Duloxetine Delayed-release Capsules (Duloxetinecapsul Figure 08)

This appears to be a graph or chart showing the percentage of patients who experienced improvement in pain after taking an unknown dose of medication once daily. The graph shows that at the end of the treatment period (represented by the X axis), 20-30% of patients experienced improvement in pain compared to their initial pain baseline (represented by BOCF, or "Baseline Observation Carried Forward"). However, without additional context or information, it is difficult to fully understand the purpose or significance of this data.*

FDA Label Image

Label Image (Lbl504360387)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.